---
title: "Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA"
description: "October ..."
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260060456.md"
published_at: "2025-10-06T13:35:54.000Z"
---

# Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA

> October ...

October ...

### Related Stocks

- [BDRX.US - Biodexa Pharmaceuticals](https://longbridge.com/en/quote/BDRX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Innospec Q4 revenue misses estimates | Innospec's Q4 revenue fell 2% to $455.6 million, missing analyst expectations of $460.87 million. However, adjusted EPS  | [Link](https://longbridge.com/en/news/276174327.md) |
| Bri-Chem Enters into Formal Supply Agreement with Reliant Technologies Inc. | Bri-Chem Corp. has entered into a formal supply agreement with Reliant Technologies Inc., effective February 17, 2026. T | [Link](https://longbridge.com/en/news/276240229.md) |
| CenterBook Partners LP Has $5.32 Million Stock Position in Ingevity Corporation $NGVT | CenterBook Partners LP reduced its stake in Ingevity Corporation (NYSE:NGVT) by 22.5% in Q3, now holding 96,334 shares v | [Link](https://longbridge.com/en/news/276234978.md) |
| Carl Icahn Cuts Share Stake In Echostar, Raises in Monro | Carl Icahn has made significant changes to his shareholdings, as reported in SEC filings. He reduced his stake in EchoSt | [Link](https://longbridge.com/en/news/276172831.md) |
| 1,777,954 Shares in DuPont de Nemours, Inc. $DD Purchased by Mondrian Investment Partners LTD | Mondrian Investment Partners LTD acquired 1,777,954 shares of DuPont de Nemours, Inc. (NYSE:DD) valued at approximately  | [Link](https://longbridge.com/en/news/276118070.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.